These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8102931

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
    McPhillips JJ, Schwemer GT, Scott DI, Zinny M, Patterson D.
    Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF.
    Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
    [Abstract] [Full Text] [Related]

  • 27. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 28. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D, Ader JL, Emal V, Bories P, Girolami JP, Suc JM.
    Arch Mal Coeur Vaiss; 1982 Jun 26; 75 Spec No():151-6. PubMed ID: 6126168
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec 26; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of R- and S-carvedilol in routinely treated Japanese patients with heart failure.
    Horiuchi I, Nozawa T, Fujii N, Inoue H, Honda M, Shimizu T, Taguchi M, Hashimoto Y.
    Biol Pharm Bull; 2008 May 26; 31(5):976-80. PubMed ID: 18451529
    [Abstract] [Full Text] [Related]

  • 32. Carvedilol: use in chronic heart failure.
    Doughty RN, White HD.
    Expert Rev Cardiovasc Ther; 2007 Jan 26; 5(1):21-31. PubMed ID: 17187454
    [Abstract] [Full Text] [Related]

  • 33. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG, Van der Niepen P, Taeymans Y, Ingels M, Piepsz A, Bossuyt AM, Block P, Six RO, Jonckheer MH, Vanhaelst L.
    J Cardiovasc Pharmacol; 1987 Jan 26; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic benefits and safety of carvedilol in the treatment of renal hypertension. An open, short term study. Carvedilol Renal Hypertension Study Group in Japan.
    Kohno M, Takeda T, Ishii M, Saruta T, Mizuno Y, Yoshimura M, Kubo S, Fukiyama K, Fujishima M.
    Drugs; 1988 Jan 26; 36 Suppl 6():129-35. PubMed ID: 2908299
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Is urethane-chloralose anaesthesia appropriate for pharmacokinetic-pharmacodynamic assessment? Studies with carvedilol.
    Bertera FM, Di Verniero CA, Mayer MA, Bramuglia GF, Taira CA, Höcht C.
    J Pharmacol Toxicol Methods; 2009 Jan 26; 59(1):13-20. PubMed ID: 18973819
    [Abstract] [Full Text] [Related]

  • 37. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy.
    Trachtman H, Del Pizzo R, Valderrama E, Gauthier B.
    Pediatr Nephrol; 1990 Sep 26; 4(5):501-4. PubMed ID: 2242316
    [Abstract] [Full Text] [Related]

  • 38. The effect of a converting enzyme inhibitor upon renal damage in spontaneously hypertensive Fawn Hooded rats.
    Westenend PJ, Nooyen YA, van der Krogt JA, van Brummelen P, Weening JJ.
    J Hypertens; 1992 May 26; 10(5):417-22. PubMed ID: 1317901
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
    Packer M, Lukas MA, Tenero DM, Baidoo CA, Greenberg BH, 369 Study Group.
    Am J Cardiol; 2006 Oct 02; 98(7A):39L-45L. PubMed ID: 17023231
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.